SARS-CoV-2-neutralising monoclonal antibodies to prevent COVID-19

Objectives: This is a protocol for a Cochrane Review (intervention) The objectives are as follows: To assess the effectiveness and safety of SARS-CoV-2-neutralising mAbs, including mAb fragments, to prevent infection with SARS-CoV-2 causing COVID-19;and to maintain the currency of the evidence, using a living systematic review approach Copyright © 2021 The Cochrane Collaboration Published by John Wiley & Sons, Ltd